Global Non-melanoma Skin Cancer Market 2024-2028

Global Non-melanoma Skin Cancer Market 2024-2028


Global Non-Melanoma Skin Cancer Market 2024-2028

The non-melanoma skin cancer market is forecasted to grow by USD 136.9 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the non-melanoma skin cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by NMSC coverage and support, increase in awareness about skin cancer, and growing initiatives by organizations.

Technavio's non-melanoma skin cancer market is segmented as below:
  • By Type
  • BCC
  • SCC
  • By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing incidence of NMSC as one of the prime reasons driving the non-melanoma skin cancer market growth during the next few years. Also, surgery considered as first-line curative approach for NMSC and high off-label use of topical treatments for NMSC will lead to sizable demand in the market.

The report on the non-melanoma skin cancer market covers the following areas:
  • Non-melanoma skin cancer market sizing
  • Non-melanoma skin cancer market forecast
  • Non-melanoma skin cancer market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-melanoma skin cancer market vendors that include 3M Co., Almirall SA, Amgen Inc., Bausch Health Companies Inc., Bristol Myers Squibb Co., Elekta AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, iCAD Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sensus Healthcare Inc., Sun Pharmaceutical Industries Ltd., Varian Medical Systems Inc., Viatris Inc., and Vidac Pharma. Also, the non-melanoma skin cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary - Data Table on Market Overview
      • Table Executive Summary - Data Table on Incremental Growth
  • Market Landscape
    • Market ecosystem
      • Table Data Table on - Parent Market
    • Market characteristics
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global Non-Melanoma Skin Cancer Market 2018 - 2022
      • Table Historic Market Size - Data Table on Global Non-Melanoma Skin Cancer Market 2018 - 2022 ($ million)
    • Type segment analysis 2018 - 2022
    • Geography segment analysis 2018 - 2022
    • Country segment analysis 2018 - 2022
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Type
    • Market segments
      • Table Data Table on Type - Market share 2023-2028 (%)
    • Comparison by Type
      • Table Data Table on Comparison by Type
    • BCC - Market size and forecast 2023-2028
      • Table Data Table on BCC - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on BCC - Year-over-year growth 2023-2028 (%)
    • SCC - Market size and forecast 2023-2028
      • Table Data Table on SCC - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on SCC - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Type
      • Table Data Table on Market opportunity by Type ($ million)
  • Customer Landscape
    • Customer landscape overview
  • Geographic Landscape
    • Geographic segmentation
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2023-2028
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Asia - Market size and forecast 2023-2028
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023-2028
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • Canada - Market size and forecast 2023-2028
      • Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • UK - Market size and forecast 2023-2028
      • Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on UK - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • Japan - Market size and forecast 2023-2028
      • Table Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Data Tables on Market opportunity by geography ($ million)
  • Drivers, Challenges, and Opportunity/Restraints
    • Market drivers
      • NMSC coverage and support
      • Increase in awareness about skin cancer
      • Growing initiatives by organizations
    • Market challenges
      • Lack of drugs in pipeline for NMSC
      • Low data availability on NMSC statistics in cancer registries
      • Increase in economic burden of NMSC
    • Impact of drivers and challenges
    • Market opportunities/restraints
      • Increasing incidence of NMSC
      • Surgery considered as first-line curative approach for NMSC
      • High off-label use of topical treatments for NMSC
  • Competitive Landscape
    • Overview
    • Competitive Landscape
    • Landscape disruption
    • Industry risks
  • Competitive Analysis
    • Companies profiled
    • Market positioning of companies
    • 3M Co.
    • Almirall SA
    • Bausch Health Companies Inc.
    • Bristol Myers Squibb Co.
    • Elekta AB
    • F. Hoffmann La Roche Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Varian Medical Systems Inc.
    • Viatris Inc.
    • Vidac Pharma
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • Data procurement
    • Data validation
    • Validation techniques employed for market sizing
    • Data synthesis
    • 360 degree market analysis
    • List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings